Abstract
Sentinel node biopsy (SNB) for axillary staging in breast cancer allows the application of more extensive pathologic examination techniques. Micrometastases are being detected more often, however, coinciding with stage migration. Besides assessing the prognostic relevance of micrometastases and the need for administering adjuvant systemic and regional therapies, there still seems to be room for improvement. In a population-based analysis, we compared survival of patients with sentinel node micrometastases with those with node-negative and node-positive disease in the era after introduction of SNB. Data from the population-based Eindhoven Cancer Registry were used on all (n = 6803) women who underwent SNB for invasive breast cancer in the Southeast Region of The Netherlands in the period 1996–2006. In 451 patients (6.6%) a sentinel node micrometastasis (pN1mi) was detected and in 126 patients (1.9%) isolated tumor cells (pN0(i+)). Micrometastases or isolated tumor cells in the SNB did not convey any significant survival difference compared with node-negative disease. After adjustment for age, pT, and grade, still no survival difference emerged pN1mi: [HR 0.9 (95% CI, 0.6–1.3)] and pN0(i+): [HR 0.4 (95% CI, 0.14–1.3)] and neither was the case after additional adjustment for adjuvant systemic therapy. Our practice-based study showed that the presence of sentinel node micrometastases in breast cancer patients has hardly any impact on breast cancer overall survival during the first years after diagnosis.
Similar content being viewed by others
References
Louwman WJ, Voogd AC, Van Dijck JAAM et al (2008) On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975–2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97–106
Schijven MP, Vingerhoets AJ, Rutten HJ et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29(4):341–350
Ververs JM, Roumen RM, Vingerhoets AJ et al (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37(8):991–999
Cox CE, Bass SS, McCann CR et al (2000) Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Ann Rev Med 51:525–542
Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 349:1864–1867
Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990
Kuijt GP, van de Poll-Franse LV, Voogd AC et al (2007) Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 33(7):832–837
Tjan-Heijnen VC, Bult P, de Widt-Levert LM et al (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70(2):81–88
Maaskant AJG, van de Poll-Franse LV, Voogd AC et al (2009) Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 113(1):173–179
van der Heiden-van der Loo M, Bezemer PD, Hennipman A et al (2006) Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32(7):710–714
de Mascarel I, Bonichon G, Coindre J et al (1992) Prognostic significance of breast cancer axillary lymph node metastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66:523–527
Hainsworth P, Tjandra J, Stillwell R et al (1993) Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459–463
Ludwig Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565–1568
Kuijt GP, Voogd AC, van de Poll-Franse LV et al (2005) The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 31:500–505
Nasser I, Lee A, Bosari S et al (1993) Occult axillary lymph node metastases in node-negative breast carcinoma. Hum Pathol 24:950–957
Fitzgibbons P, Page D, Weaver D et al (2000) Prognostic factors in breast cancer: college of American Pathologists Consensus statement 1999. Arch Pathol Lab Med 124:966–978
Grabau D (2008) Breast cancer patients with micrometastases only: is a basis provided for tailored treatment? Surg Oncol 17:211–217
Tan LK, Giri D, Hummer AJ et al (2008) Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26:1803–1809
Mc Shane LM, Altman DG, Sauerbrei W et al (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100:229–235
Hermanek P, Sobin LH (eds) (1987) UICC TNM classification of malignant tumors. Springer, Berlin, pp 94–99
Roumen RMH, Pijpers HJ, Thunissen FBJM et al (2000) Samenvatting van de richtlijn “Schildwachtklierbiopsie bij mammacarcinoom”. Ned Tijdschr Geneeskd 144:1864–1867
Yeatman TJ, Nicolson GL (1993) Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis. Semin Surg Oncol 9:256–263
Yeatman TJ, Cox CE (1999) The significance of breast cancer lymph node micrometastases. Surg Oncon Clin N Am 3:481–496
Mansi JL, Gogas H, Bliss JM et al (1999) Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 354:197–202
Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988
Chen SL, Hoehne FM, Guiliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14(12):3378–3384
Gobardhan PD, Elias SG, Madsen EVE et al (2009) Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 20(1):41–48
Hansen NM, Grube B, Ye X et al (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. JCO 27:4679–4684
de Boer M, van Deurzen CHM, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. NEJM 361(7):653–663
Author information
Authors and Affiliations
Corresponding author
Additional information
An invited commentary to this article can be found at doi:10.1007/s10549-010-1176-5.
Rights and permissions
About this article
Cite this article
Maaskant-Braat, A.J., van de Poll-Franse, L.V., Voogd, A.C. et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat 127, 195–203 (2011). https://doi.org/10.1007/s10549-010-1086-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1086-6